» Articles » PMID: 11583868

Mechanisms Behind the Prognostic Value of Troponin T in Unstable Coronary Artery Disease: a FRISC II Substudy

Overview
Date 2001 Oct 5
PMID 11583868
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study was designed to elucidate possible mechanisms for the prognostic value of troponin T (tnT).

Background: The reasons for the adverse prognosis associated with elevation of troponins in unstable coronary artery disease are poorly understood.

Methods: Patients enrolled in the Fast Revascularization during InStability in CAD (FRISC-II) trial were included. Clinical characteristics, findings at echocardiography and coronary angiography, and prognosis were evaluated in relation to different tnT levels.

Results: Absence of significant coronary stenosis was more frequent and three-vessel disease or left main stem stenosis was less frequent in patients without, compared with, detectable tnT. The occurrence of visible thrombus increased with rising levels of tnT. In the group with the highest levels of tnT, occlusion of the left circumflex artery was more common than in the three other tnT groups, as was a left ventricular ejection fraction below 0.45. The one-year risk of death in the noninvasive arm of the study increased by increasing levels of tnT (1.6% to 4.6%), whereas the risk of myocardial infarction showed an inverted U-shaped curve and was lower in the lowest (5.5%) and highest (8.4%) tnT groups than in the two intermediate groups (17.5% and 16.2%).

Conclusions: Any detectable elevation of tnT raises the probability of significant coronary stenosis and thrombus formation and is associated with an increased risk of reinfarction and death. However, at a more pronounced elevation of troponin, a higher proportion of patients has a persistent occlusion of the culprit vessel and reduced left ventricular function, associated with a high mortality but a modest risk of reinfarction.

Citing Articles

Infarct Size and Long-Term Clinical Outcomes of Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Coronary Artery Stenting: A Prospective Randomized Study.

Yabe T, Noike R, Okubo R, Amano H, Ikeda T Int J Angiol. 2023; 32(1):56-65.

PMID: 36727153 PMC: 9886453. DOI: 10.1055/s-0042-1746417.


Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry.

Eggers K, James S, Jernberg T, Lindahl B EuroIntervention. 2022; 18(7):582-589.

PMID: 35352681 PMC: 10241271. DOI: 10.4244/EIJ-D-21-00982.


Risk Stratification of Patients with Acute Coronary Syndrome.

Bauer D, Tousek P J Clin Med. 2021; 10(19).

PMID: 34640592 PMC: 8509298. DOI: 10.3390/jcm10194574.


The clinical effect of recombinant human brain natriuretic peptide on asymptomatic peri-procedural myocardial injury after percutaneous transluminal coronary angioplasty.

Liang L, Tang R, Xie Q, Han J, Li W Sci Rep. 2020; 10(1):15902.

PMID: 32985551 PMC: 7522987. DOI: 10.1038/s41598-020-72710-3.


Cardioprotective effect of acupuncture for percutaneous coronary intervention-related myocardial injury in patients with coronary artery disease: A protocol for systematic review and meta-analysis.

Chen C, Zhu X, Zhou K, Li D, Lin Q Medicine (Baltimore). 2020; 99(20):e20135.

PMID: 32443326 PMC: 7254684. DOI: 10.1097/MD.0000000000020135.